Cargando…
Insulin prevents and reverts simvastatin-induced toxicity in C2C12 skeletal muscle cells
Simvastatin is an inhibitor of the 3-hydroxy-3-methylglutaryl-CoA reductase used for decreasing low density lipoprotein (LDL)-cholesterol in patients. It is well-tolerated but can cause myopathy. Our aims were to enlarge our knowledge regarding mechanisms and effects of insulin on simvastatin-associ...
Autores principales: | Sanvee, Gerda M., Bouitbir, Jamal, Krähenbühl, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520350/ https://www.ncbi.nlm.nih.gov/pubmed/31092879 http://dx.doi.org/10.1038/s41598-019-43938-5 |
Ejemplares similares
-
Molecular Toxicological Mechanisms of Synthetic Cathinones on C2C12 Myoblasts
por: Zhou, Xun, et al.
Publicado: (2019) -
Simvastatin Impairs Glucose Homeostasis in Mice Depending on PGC-1α Skeletal Muscle Expression
por: Panajatovic, Miljenko Valentin, et al.
Publicado: (2020) -
Statins and Insulin Resistance
por: Sanvee, GM, et al.
Publicado: (2020) -
Effects of Simvastatin on Lipid Metabolism in Wild-Type Mice and Mice with Muscle PGC-1α Overexpression
por: Panajatovic, Miljenko V., et al.
Publicado: (2021) -
PGC-1α and MEF2 Regulate the Transcription of the Carnitine Transporter OCTN2 Gene in C2C12 Cells and in Mouse Skeletal Muscle
por: Novakova, Katerina, et al.
Publicado: (2022)